Skip to main content
Signal8

Deignan Charles A.

SEC insider (Form 3/4/5 filer). CIK 0001664690. Chief Financial Officer at Clearside Biomedical, Inc. (CLSD). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 8, 2025. Located in ALPHARETTA, GA.

Companies Deignan Charles A. has filed insider reports for

  • Clearside Biomedical, Inc. (CLSD): Officer, Chief Financial Officer
Deignan Charles A. profile photo

Deignan Charles A.

CIK: 0001664690

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Clearside Biomedical, Inc. logo
CLSD

Clearside Biomedical, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Clearside Biomedical, Inc. logo
    CLSD

    Clearside Biomedical, Inc.

    Jan 8, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    200K shares-

1-1 of 1